Chemoembolisation of liver neoplasm has been made for the first time in ТR

8 April 2014, Tuesday

Chemoembolisation of liver neoplasm has been made for the first time in Tatarstan Republic to 75 years old patient of oncologic unit of SAHI TR “Emergency Hospital” of Naberezhnye Chelny.
Earlier the patient with stomach disease received complex therapy. However during last examination the secondary focus of 8th segment of liver has been detected. That’s why the operating crew under the direction of surgeon Zagidullin Bulat Iskandarovich and oncologist Makarov Nickolay Nickolaevich had applied the method of selective chemoembolisation of vas, feeding neoplasms. The solution of the embolizing material impregnated by "Doxorubicinum" has been injected in the vas, feeding neoplasm.

Professor Taziev R. M said: «Last years method of chemoembolisation is used widely in oncologic practice for treatment of primary and metastatic cancer of liver. The liver parenchyma is supplied with portal blood on 75-80 % and only on 20-25 % with arterial blood, but blood supply of   liver’s neoplasm is exceptional arterial. The method of chemoembolisation allows to bring the antitumoral drug directly to lesion’s focus without augmentation of concentration of drug and its toxic effect.
Experience of application of this method proves its efficiency at treatment of patients with primary and metastatic cancer, considerably enlarging life of the patients. Wider usage of method of chemoembolisation in treatment of patients with operable cancer as step of preparation for operation, and for palliative treatment of non-operable patients for augmentation of duration of their life is planned.
The basic condition of usage of this method of treatment is the presence of the necessary equipment and specialists. Emergency Hospital has all possibilities”.
Implementation of this method is execution of the order of TR Health Minister A.Ju.Vafin given on one of weekly video conferences.

SUBSCRIBE FOR NEWS
All content on this site is licensed under
Creative Commons Attribution 4.0 International